Chemical Structure (Doxazosin 01)
Doxazosin Tablet
Product Images NDC 71335-9672
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-9672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 3 (Doxazosin 02)
This text provides a comparison of the maximum flow rate, symptom score, and mean change in baseline for different treatments for benign prostatic hyperplasia (BPH). The studies evaluated the effects of doxazosin in different doses and titrations compared to placebo. The first study titrated to a maximum dose of 8ng, and the second study titrated to a fixed dose for 14 weeks. The third study titrated to fixed doses for 12 weeks. The symptom score was measured using the AUA questionnaire, and the modified Boyarsky questionnaire was used in study 2. The text mentions significant changes in symptom score and mean flow rate for doxazosin compared to placebo in some cases.*
Figure 1 (Doxazosin 03)
The text is describing a study that shows the mean change in total symptoms and an increase in maximum urinary flow rate from baseline after the administration of Doxazosin. The study was conducted with 47 participants, and the duration of treatment was measured in weeks. The graph shows the comparison between placebo and Doxazosin titration up to a maximum of 8mg. Some data is not properly recognized by , leading to inaccuracies.*
Label (Lbl713359672)
This is a description of Doxazosin Mesylate Tablets containing 4 mg of the drug. The tablets come in a bottle of 100 and are stored between temperatures of 20-25°C, with excursions permitted between 15-30°C. The package was repackaged by Bryant Ranch Prepack, Inc. and manufactured by Upsher-Smith Laboratories, LLC. The tablets are only available through prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
